UCLA Research Program in Pharmaceutical Economics and Policy
Parent: UCLA
eScholarship stats: Breakdown by Item for December, 2024 through March, 2025
Item | Title | Total requests | Download | View-only | %Dnld |
---|---|---|---|---|---|
5fg9n284 | Drug Evaluations: Type I vs. Type II Errors | 161 | 8 | 153 | 5.0% |
7vz4h41m | Differences in Managed Care Drug Formularies: What Can Consumers Learn? | 33 | 7 | 26 | 21.2% |
0d90459k | The Productivity of Health Care and Pharmaceuticals: An International Comparison | 21 | 3 | 18 | 14.3% |
46p5p6p4 | Do Managed Care Drug Formularies Signal Health Plan Coverage Generosity | 21 | 4 | 17 | 19.0% |
85s5w09k | Pharmaceutical Prices and Expenditures | 17 | 3 | 14 | 17.6% |
5d8758z2 | The Pharmaceutical Research and Development Process, and its Costs | 16 | 3 | 13 | 18.8% |
Note: Due to the evolving nature of web traffic, the data presented here should be considered approximate and subject to revision. Learn more.